Tetrahydroquinoline derivatives as opioid receptor antagonists

被引：8

作者：

Zhang, Cunyu ^{[1
]}

Westaway, Susan M. ^{[2
]}

Speake, Jason D. ^{[1
]}

Bishop, Michael J. ^{[1
]}

Goetz, Aaron S. ^{[3
]}

Carballo, Luz Helena ^{[3
]}

Hu, Mike ^{[4
]}

Epperly, Andrea H. ^{[4
]}

机构：

[1] GlaxoSmithKline, Dept Med Chem, Res Triangle Pk, NC 27709 USA

[2] GlaxoSmithKline, Immunoinflammat CEDD, Stevenage SG1 2NY, Herts, England

[3] GlaxoSmithKline, Mol Discovery Res, Screening & Compound Profiling, Res Triangle Pk, NC 27709 USA

[4] GlaxoSmithKline, Dept Drug Metab & Pharmacokinet, Res Triangle Pk, NC 27709 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2011年 / 21卷 / 02期

关键词：

Tetrahydroquinoline; Opioid; Antagonist; NALOXONE; ANALOGS; RATS; FOOD;

D O I：

10.1016/j.bmcl.2010.12.010

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Opioid receptors play an important role in both behavioral and homeostatic functions. We herein report tetrahydroquinoline derivatives as opioid receptor antagonists. SAR studies led to the identification of the potent antagonist 2v, endowed with 1.58 nM (K-i) functional activity against the mu opioid receptor. DMPK data suggest that novel tetrahydroquinoline analogs may be advantageous in peripheral applications. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：670 / 676

页数：7

共 50 条

[31] Comparison between novel μ-opioid antagonists and naltrexone of the central and peripheral μ-opioid receptor
Sakurai, Einosuke
Takasu, Masako
Hamada, Tamiko
Kojima, Kazuko
Inoue, Hitoshi
Houjyou, Naomi
Kawauchi, Chisato
Tanaka, Yukio
Muraki, Yukiko
ACTA PHARMACOLOGICA SINICA, 2006, 27 : 248 - 248
[32] PERIPHERALLY ACTING MU-OPIOID RECEPTOR ANTAGONISTS
Martinez-Cox, Stephanie
Espinosa, Karla
Friece, Chad
Rahman, Anita
GASTROENTEROLOGY NURSING, 2017, 40 (06) : 517 - 522
[33] Oxycodone combined with opioid receptor antagonists: efficacy and safety
Davis, Mellar
Goforth, Harold W.
Gamier, Pam
EXPERT OPINION ON DRUG SAFETY, 2013, 12 (03) : 389 - 402
[34] THE DESIGN OF DELTA-SELECTIVE OPIOID RECEPTOR ANTAGONISTS
PORTOGHESE, PS
FARMACO, 1993, 48 (02): : 243 - 251
[35] Peripherally acting opioid receptor antagonists in pediatric patients
Nair, Abhijit
JOURNAL OF ANAESTHESIOLOGY CLINICAL PHARMACOLOGY, 2018, 34 (02) : 254 - 255
[36] The role of opioid receptor antagonists in the treatment of opioid-induced constipation: a review
Wojciech Leppert
Advances in Therapy, 2010, 27 : 714 - 730
[37] SELECTIVE NATREXONE-DERIVED OPIOID RECEPTOR ANTAGONISTS
TAKEMORI, AE
PORTOGHESE, PS
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1992, 32 : 239 - 269
[38] OPIOID ANTINOCICEPTIVE EFFECTS OF DELTA-RECEPTOR ANTAGONISTS
LEANDER, JD
GESELLCHEN, PD
MENDELSOHN, LG
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1988, 29 (02) : 351 - 355
[39] Opioid receptor antagonists in psychiatry: Beyond drug addiction
Rénéric J.-P.
Bouvard M.P.
CNS Drugs, 1998, 10 (5) : 365 - 382
[40] Opioid receptor in antagonists in psychiatry -: Beyond drug addiction
Rénéric, JP
Bouvard, MP
CNS DRUGS, 1998, 10 (05) : 365 - 382

← 1 2 3 4 5 →